[1] Lower GSH levels are implicated in many diseases and GSH has been tried in the management of Alzheimers disease, Parkinsons disease, multiple sclerosis, alcoholic hepatitis, atherosclerosis, acquired immunodeficiency syndrome, and chronic fatigue syndrome
Clinical trials consistently used 1 mg (or occasionally 2 mg) as the entry point, and starting higher significantly increases the risk of gastrointestinal side effects
Impact on current patients Sudden discontinuation of compounded semaglutide prescriptions by WW is distressful for patients who were using compounded semaglutide for weight management
Heartburn that doesnt respond to any of the above measures and is occurring daily, pain or difficulty swallowing, a sensation of food getting stuck, unexplained weight loss beyond what the medication accounts for, or heartburn accompanied by chest pain that radiates to the arm or jaw are all symptoms requiring medical evaluation rather than self-management